The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD
| Description | |
| Date de publication | |
| Auteurs | Gargaun E, Falcone S, Sole G, Durigneux J, Urtizberea A, Cuisset JM, Benkhelifa-Ziyyat S, Julien L, Boland A, Sandron F, Meyer V, Deleuze JF, Salgado D, Desvignes JP, Beroud C, Chessel A, Blesius A, Krahn M, Levy N, Leturcq F and Pietri-Rouxel F |
| Revue | |
| Année | 2,021 |
| Département / Service | |
| Laboratoire | |
| Impact Factor | 6.08 |
| Institut | JACOB |
| url DOI | 10.3390/biomedicines9020219 |